Company profile
Transcode Therapeutics company profile
TransCode Therapeutics is an emerging RNA oncology company committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, which they believe has blockbuster potential, targets an RNA molecule that is the driver of metastatic disease across multiple tumor types and has been validated pre-clinically in its lab at MGH.
Business identity
- Contact email
- [email protected]
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0-$1M
- Founded
- 2016-01-01
Headquarters
- Headquarters
- Calumet City, Illinois, United States
- Postal code
- 02458
- Country code
- US
- Continent
- North America